---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006052"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T23:01:13.254706+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Indaptus enters $20M standby equity line with Yorkville; issues 305,960 commitment shares

## Summary
- Up to $20M equity purchase agreement with YA II PN (Yorkville) over 36 months.
- Shares sold at 97% of lowest 3-day VWAP; 305,960 commitment shares and $25k fee issued.
- Exchange cap 2,823,244 shares (19.99% of outstanding) unless price ≥$0.81722 or shareholder approval.
- Terminates prior Lincoln Park Capital purchase agreement from December 2022.
- Registration statement required before any advances can be drawn.

## SEC filing metadata
- accession: 0001493152-25-006052
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315225006052/0001493152-25-006052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315225006052/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006052
- JSON: https://secwatch.observer/filing/0001493152-25-006052.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.